Klonopin Protein Binding Percentage
Klonopin (clonazepam) binds 85% to plasma proteins, mainly albumin, across therapeutic doses including Bindo Pharma's 1 mg formulation. This value holds steady for adults and does not vary significantly by dosage strength.[1][2]
Does Binding Change with 1 mg Dose or Brand?
No. Protein binding for clonazepam is concentration-independent at standard doses like 1 mg, remaining around 85% regardless of plasma levels or generic manufacturers like Bindo Pharma. Bindo's version matches the reference listed drug's pharmacokinetics.[2][3]
What Affects Klonopin Protein Binding?
Factors like low albumin (e.g., in liver disease or malnutrition) can reduce binding to 50-70%, increasing free drug levels and effects. Displacement by drugs like salicylates or valproate is possible but rare.[1][4]
Clinical Impact of 85% Binding
High binding limits free drug availability, but Klonopin has a long half-life (18-50 hours), so dose adjustments focus more on metabolism via CYP3A4 than binding. No specific adjustments for Bindo's 1 mg tablets.[2]
[1]: FDA Label for Klonopin (Clonazepam)
[2]: RxList - Clonazepam Pharmacokinetics
[3]: Drugs.com - Clonazepam Protein Binding
[4]: Clinical Pharmacology Review - Clonazepam